| 1015-63-0 |
|
1H-Pyrrole, 2,3,4,5-tetramethyl-1-phenyl- |
C14H17N |
- |
-
|
| 1015-64-1 |
|
1-Phenyl-6-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione |
C11H10N2O2 |
202.2100 |
-
|
| 1015-65-2 |
|
2,4,6(1H,3H,5H)-Pyrimidinetrione, 1-cyclohexyl- |
C10H14N2O3 |
- |
-
|
| 1015-74-3 |
|
4-nitro-1,2-dihydroacenaphthylene |
C12H9NO2 |
199.2100 |
-
|
| 1015-77-6 |
|
1H-1,4-Benzodiazepine-2,5-dione, 3,4-dihydro-1,4-dimethyl- |
C11H12N2O2 |
- |
-
|
| 1015-84-5 |
|
1-hydroxy-3,4-dioxo-3,4-dihydronaphthalene-2-carbonitrile |
C11H5NO3 |
199.1600 |
-
|
| 1015-89-0 |
6(5H)-菲啶酮 |
6(5H)-Phenanthridone |
C13H9NO |
195.2200 |
-
|
| 1015-97-0 |
|
1H-benzo[f]indazole-4,9-dione |
C11H6N2O2 |
198.1800 |
-
|
| 10150-12-6 |
|
4-Thiazolidinone,5-[(1,3-diethyl-1,3-dihydro-2H-benzimidazol-2-ylidene)ethylidene]-3-ethyl-2-thioxo- |
C18H21N3OS2 |
- |
-
|
| 10150-26-2 |
|
1-amino-4-[(2-methoxy-5-{[2-(sulfooxy)ethyl]sulfonyl}phenyl)amino]-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid |
C23H20N2O12S3 |
612.6100 |
-
|
| 10150-27-3 |
2-[2-(二苯基膦)乙基]吡啶 |
2-[2-(Diphenylphosphino)Ethyl]Pyridine,Min.97% |
C19H18NP |
291.3300 |
-
|
| 10150-29-5 |
|
1,2-Ethanediamine, N-[(tetrahydro-2-furanyl)methyl]- |
C7H16N2O |
- |
-
|
| 10150-87-5 |
|
4-acetoxy-2-butanone |
C6H10O3 |
130.1400 |
-
|
| 10150-92-2 |
|
2-Pentenoic acid, 4-hydroxy-, ethyl ester, (2E)- |
C7H12O3 |
- |
-
|
| 10150-93-3 |
(2E)-4-氧代-2-戊烯酸乙酯 |
Ethyl (2E)-4-Oxopent-2-Enoate |
C7H10O3 |
142.1500 |
-
|
| 10150-95-5 |
|
2(3H)-Furanone, dihydro-4,5-dimethyl-, cis- |
C6H10O2 |
- |
-
|
| 10150-96-6 |
|
2(3H)-Furanone, dihydro-4,5-dimethyl-, (4R,5S)-rel- |
C6H10O2 |
- |
-
|
| 101500-15-6 |
|
N-(4-bromophenyl)-3-piperidin-1-ylbutanamide |
C15H21BrN2O |
325.2400 |
-
|
| 101500-43-0 |
|
Phosphoric acid, calcium salt (1:1), solid soln. with calcium chloride, calcium fluoride, calcium oxide, phosphorus oxide (P2O5) and strontium oxide, antimony and manganese-doped |
- |
- |
-
|
| 101500-64-5 |
|
Furo[3,4:3,4]cyclobuta[1,2:3,4]cyclobut[1,2-d]isoxazole (9CI) |
C9H3NO2 |
- |
-
|